These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8024672)

  • 1. Effect of clozapine treatment on serotonin-2-receptor binding in the blood platelets of schizophrenic patients.
    Arora RC; Meltzer HY
    Neuropsychopharmacology; 1994 Apr; 10(2):109-14. PubMed ID: 8024672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet serotonin-2 receptors in schizophrenia: effects of illness and neuroleptic treatment.
    Pandey SC; Sharma RP; Janicak PG; Marks RC; Davis JM; Pandey GN
    Psychiatry Res; 1993 Jul; 48(1):57-68. PubMed ID: 8105499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin2 receptor binding in blood platelets of schizophrenic patients.
    Arora RC; Meltzer HY
    Psychiatry Res; 1993 May; 47(2):111-9. PubMed ID: 8341764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin function and treatment response to clozapine in schizophrenic patients.
    Kahn RS; Davidson M; Siever L; Gabriel S; Apter S; Davis KL
    Am J Psychiatry; 1993 Sep; 150(9):1337-42. PubMed ID: 8394651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of typical and atypical antipsychotic drugs on 5-HT2 receptor density in rat cerebral cortex.
    Matsubara S; Meltzer HY
    Life Sci; 1989; 45(15):1397-406. PubMed ID: 2571912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of serotonin-dopamine interactions in the action of clozapine.
    Meltzer HY
    Br J Psychiatry Suppl; 1992 May; (17):22-9. PubMed ID: 1358125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D1-, D2-, and 5-HT2-receptor occupancy in clozapine-treated patients.
    Farde L; Nordström AL; Nyberg S; Halldin C; Sedvall G
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():67-9. PubMed ID: 7961577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cimetidine-induced increase in prolactin secretion in schizophrenia: effect of clozapine.
    Meltzer HY; Maes M; Lee MA
    Psychopharmacology (Berl); 1993; 112(1 Suppl):S95-104. PubMed ID: 7831446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clozapine: new research on efficacy and mechanism of action.
    Meltzer HY; Bastani B; Ramirez L; Matsubara S
    Eur Arch Psychiatry Neurol Sci; 1989; 238(5-6):332-9. PubMed ID: 2569975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized trial comparing clozapine and typical neuroleptic drugs in non-treatment-resistant schizophrenia.
    Meltzer HY; Bobo WV; Lee MA; Cola P; Jayathilake K
    Psychiatry Res; 2010 May; 177(3):286-93. PubMed ID: 20378185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of schizophrenic symptoms and changes in plasma HVA concentrations, plasma anti-D2 and anti-5-HT2 receptor activities with clozapine.
    Yamada K; Kanba S; Wang ZC; Suzuki E; Fang YY; Yan HG; Nibuya M; Yagi G; Asai M
    Psychiatry Clin Neurosci; 1996 Oct; 50(5):291-4. PubMed ID: 9201793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet serotonin transporter in schizophrenic patients with and without neuroleptic treatment.
    Govitrapong P; Mukda S; Turakitwanakan W; Dumrongphol H; Chindaduangratn C; Sanvarinda Y
    Neurochem Int; 2002 Oct; 41(4):209-16. PubMed ID: 12106771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Atypical tricyclic neuroleptics for treatment of schizophrenia. Clothiapine and clozapine].
    Seminara G; Trassari V; Prestifilippo N; Chiavetta R; Calandra C
    Minerva Psichiatr; 1993 Jun; 34(2):95-9. PubMed ID: 8105359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of typical and atypical antipsychotic drugs based on in vivo occupancy of serotonin2 and dopamine2 receptors.
    Stockmeier CA; DiCarlo JJ; Zhang Y; Thompson P; Meltzer HY
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1374-84. PubMed ID: 8103793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet 5-HT(2A) receptors in schizophrenic patients with and without neuroleptic treatment.
    Govitrapong P; Chagkutip J; Turakitwanakan W; Srikiatkhachorn A
    Psychiatry Res; 2000 Sep; 96(1):41-50. PubMed ID: 10980325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic treatment with clozapine or haloperidol differentially regulates dopamine and serotonin receptors in rat brain.
    O'Dell SJ; La Hoste GJ; Widmark CB; Shapiro RM; Potkin SG; Marshall JF
    Synapse; 1990; 6(2):146-53. PubMed ID: 2237777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MAO inhibitory side effects of neuroleptics and platelet serotonin content in schizophrenic patients.
    Mészáros Z; Borcsiczky D; Máté M; Tarcali J; Tekes K; Magyar K
    J Neural Transm Suppl; 1998; 52():79-85. PubMed ID: 9564610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An overview of the mechanism of action of clozapine.
    Meltzer HY
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():47-52. PubMed ID: 7961573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of clozapine on d-fenfluramine-evoked neuroendocrine responses in schizophrenia and its relationship to clinical improvement.
    Curtis VA; Wright P; Reveley A; Kerwin R; Lucey JV
    Br J Psychiatry; 1995 May; 166(5):642-6. PubMed ID: 7620750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased platelet membrane [3H]-LSD binding in patients on chronic neuroleptic treatment.
    Schächter M; Geaney DP; Grahame-Smith DG; Cowen PJ; Elliott JM
    Br J Clin Pharmacol; 1985 Apr; 19(4):453-7. PubMed ID: 2859873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.